Effects of intracellular cyclic AMP modulators on human eosinophil survival, degranulation and CD11b expression

International Archives of Allergy and Immunology

Volumn 117, Issue 2, 1998, Pages 138-145

  Momose, T ^a   Okubo, Y ^a   Horie, S ^a   Suzuki, J ^a   Isobe, M ^a   Sekiguchi, M ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD11b; Cyclic AMP; Degranulation; Eosinophils; Phosphodiesterase inhibitors; Procaterol; Survival; Theophylline

Indexed keywords

BUCLADESINE; CD11B ANTIGEN; CYCLIC AMP; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5; KF 19514; MIRLINONE; PHOSPHODIESTERASE INHIBITOR; PROCATEROL; THEOPHYLLINE; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ARTICLE; CELL ISOLATION; CELL SURVIVAL; CONTROLLED STUDY; DEGRANULATION; DRUG MECHANISM; EOSINOPHIL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

BUCLADESINE; CELL DEGRANULATION; CELL SURVIVAL; CYCLIC AMP; EOSINOPHILS; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGE-1 ANTIGEN; PHOSPHODIESTERASE INHIBITORS; PLATELET ACTIVATING FACTOR; PROCATEROL; RHINITIS, ALLERGIC, PERENNIAL;

EID: 0031782935     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024001     Document Type: Article

References (33)

1. Persson CG: Overview of effects of theophylline. J Allergy Clin Immunol 1986;78: 780-787.
2. Pearce FL, Befus AD, Gauldie J, Bienenstock J: Mucosal mast cells. II. Effects of anti-allergic compounds on histamine secretion by isolated mast cells. J Immunol 1982;128:2481-2486.
3. Louis RE, Radermecker MF: Substance P induced histamine release from human basophils. skin and lung fragments: Effect of nedocromil sodium and theophylline. Int Arch Allergy Appl Immunol 1990;92:329-333.
4. Coskey LA, Bitting J, Roth MD: Inhibition of natural killer cell activity by therapeutic levels of theophylline. Am J Respir Cell Mol Biol 1993;9:659-665.
5. Rivkin I, Neutze JA: Influence of cyclic nucleotides and phosphodiesterase inhibitors on in vitro human blood neutrophil chemotaxis. Arch Int Pharmacodyn 1977;228:196-204.
6. Kraft M, Pak J, Borish L, Martin RJ: Theophylline's effect on neutrophil function and the late asthmatic response. J Allergy Clin Immunol 1996;98:251-257.
7. Torphy TJ, Undem BJ: Phosphodiesterase inhibitors: New opportunities for the treatment of asthma. Thorax 1991;46:512-523.
8. Banner KH, Page CP: Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma. Eur Respir J 1995;8:996-1000.
9. Persson CGA: Xanthines as airway anti-inflammatory drugs. J Allergy Clin Immunol 1988;81:615-617.
10. Ward AJM, McKenniff M, Evans JM, Page CP, Costello JF: Theophylline: An immunomodulatory role in asthma? Am Rev Respir Dis 1993;147:518-523.
11. Banner KH, Page CP: Effect of type III and IV isozyme selective PDE inhibitors on proliferation of human peripheral blood mononuclear cells. Br J Pharmacol 1994;113:89-92.
12. Frigas E, Gleich GJ: The eosinophil and pathophysiology of asthma. J Allergy Clin Immunol 1986;77:527-537.
13. Manzini S, Perretti F, Abelli L, Evangelista S, Seeds EAM, Page CP: Isbufylline, a new xanthine derivative, inhibits airways hyperresponsiveness and airways inflammation in guineapigs. Eur J Pharmacol 1993;249:251-257.
14. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB: IL-5 enhances the in vitro adhesion of human eosinophils but not neutrophils. in a leucocyte integrin (CD11b/18)-dependent manner. Immunology 1990;71: 258-265.
15. Horie S, Kita H: CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocytemacrophage colony-stimulating factor and platelet-activating factor. J Immunol 1994; 152:5457-5467.
16. Hossain M, Okubo Y, Horie S, Sekiguchi M: Analysis of recombinant human tumor necrosis factor-α-induced CD4 expression on human eosinophils. Immunology 1996;88:301-307.
17. Hossain M, Okubo Y, Sekiguchi M: Eosinophil viability-enhancing activity in mite-sensitive bronchial asthma. Intern Med 1994;33: 529-535.
18. Okubo Y, Hossain M, Kai R, Sato E, Honda T, Sekiguchi M, Itoh S, Takatsu K: Adhesion molecules on eosinophils in acute eosinophilic pneumonia. Am J Respir Crit Care Med 1995; 151:1259-1262.
19. Hartnell A, Moqbel R, Walsh GM, Bradley B, Kay AB: Fcγ and CD11/CD18 receptor expression of normal density and low density human eosinophils. Immunology 1990;69:264-270.
20. Romain A: New aspects of the therapeutic potential of theophylline in asthma. J Allergy Clin Immunol 1989;83:548-553.
21. Yukawa T, Kroegel C, Dent G, Chanez P, Ukena D, Barnes PJ: Effect of theophylline and adenosine on eosinophil function. Am Rev Respir Dis 1989;140:327-333..
22. Kita H, Abu-Ghazaleh RI, Gleich RJ: Regulation of Ig-induced eosinophil degranulation by adenosine 3′5′ cyclic monophosphate. J Immunol 1991;146:2712-2718.
23. 2-adrenergic receptors on eosinophils. Am Rev Respir Dis 1990;141:1446-1452.
24. Clutterbuck EJ, Hirst EMA, Sanderson CJ: Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-16, IL-6 and GM-CSF. Blood 1989;73: 1504-1512.
25. Wang JM, Rambaldi A, Biondi A, Chen ZG, Sanderson CJ, Mantovani A: Recombinant human inlerleukin-5 is a selective eosinophil chemoattractant. Eur J Immunol 1989;19:701-705.
26. Yamaguchi Y, Hayashi Y, Sugama Y, Mura Y, Kasahara T, Kitamura S, Torisu M, Mita S, Tominaga A, Takatsu K: Highly purified murine interleukin 5 (IL-S) stimulates eosinophil function and prolongs in vitro survival. J Exp Med 1988;176:1737-1742.
27. Lopez AF, Williamson DJ, Gamble JR, Begley CG, Harlan M, Klebanoff SJ, Waltersdorph A, Wong G, Clark SC, Vadas MA: Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature neutrophil and eosinophil function, surface receptor expression and survival. J Clin Invest 1986; 78:1220-1228.
28. Hallsworth MP, Giembycz MA, Barnes PJ, Lee TH: Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF. Br J Pharmacol 1996;117:79-86.
29. Lagente V, Prumiaux MP, Junien JL, Moodley I: Modulation of cylokine-induced eosinophil infiltration by phosphodiesterase inhibitors. Am J Respir Crit Care Med 1995;151:1720-1724.
30. Kroegel C, Yukawa T, Dent G, Venge P, Chung KF, Barnes PJ: Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol 1989;142:3518-3526.
31. 2-adrenergic bronchodilator in conscious guinea pigs. Arerugi 1985;34:999-1005.
32. Hone S, Okubo Y, Hossain M, Momose T, Suzuki J, Isobe M, Sekiguchi M: Intracellular adhesion molecule-1 on eosinophils is involved in eosinophil protein X release induced by cytokines. Immunology 1997;90:301-307.
33. Underwood DC, Kotzer CJ, Bochnowicz S, Osborn RR, Luttamann MA, Hay DW, Trophy TJ: Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on brochospasm and pulmonary eosinophil influx in guinea pigs. J Pharmacol Exp Ther 1994;270:250-259.